-
Your clinic has distributed brochures on contraceptive methods, put up posters in the waiting room and exam rooms, and passed out printed information along with pill packs.
-
How often do you include counseling on long-acting reversible contraceptives in your discussions of birth controls? Look for new opportunities, according to a recent presentation by Michael Policar, MD, MPH, medical director of the University of California San Francisco/Family PACT Program Support and Evaluation in Sacramento.
-
Clinicians are familiar with use of dedicated emergency contraceptive (EC) products such as Plan B One-Step (Teva Pharmaceuticals USA) and Next Choice (Watson Pharmaceuticals), as well as the EC use of the copper T380A intrauterine device (ParaGard IUD, Duramed Pharmaceuticals).
-
Flip through your patient files from the last week. If you see heavy menstrual bleeding checked several times in your charts, there's a good reason: One-third of all women report such bleeding at some point during their lives.
-
Shannon is a 15-year-old patient who is sexually active. She has previously used oral contraceptives, but Shannon experienced an unplanned pregnancy when she missed several days of pills in her pill pack and failed to come in for emergency contraception. What birth control methods can you offer?
-
With partisan fighting increasingly the norm in Washington, one of the few potential points of agreement might be federal funding for so-called home visiting programs.
-
Educate adolescents and young women about human papillomavirus (HPV) with new materials provided by the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) "Be Confident!" campaign.
-
Lynch Syndrome (LS) is a familial colorectal cancer syndrome, which occurs as a result of autosomal dominant inheritance of DNA mismatch repair genes.
-
-
In this issue: Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.
